fouremm, excellent perspectives. Thanks. This is the issue.

fouremm wrote - To me the latest presentation did absolutely nothing to improve this situation, just more excited talk but absolutely nothing concrete. It would almost seem as if they delayed a week just to give the impression they are really close to giving us something concrete. 

One must scratch one's head and ponder why the BOD is keeping Don in place when a highly qualified and respected biotech investment team could be brought in quickly and the value of this (these companies) could be realized quickly (with some dilution, I suspect, but what's new).

Wouldn't it be nice and refreshing to ask the scientists at RVX what they would recommend. We do not hear enough from them in my opinion.

So here is a challenge to all - "why is the BOD leaving Don in his position as CEO and Chairman of the BOD?".

GLTA         :)

Toinv